Subcutaneously administered dexmedetomidine is efficiently absorbed and is associated with attenuated cardiovascular effects in healthy volunteers.
Panu UusaloD Al-RamahiI TilliR A AantaaM ScheininT I SaariPublished in: European journal of clinical pharmacology (2018)
NCT02724098 . EUDRA CT number 2015-004698-34 .